Interleukin-1β and the interleukin-1 receptor antagonist act in the striatum to modify excitotoxic brain damage in the rat

European Journal of Neuroscience

Volumn 10, Issue 3, 1998, Pages 1188-1195

  Lawrence, Catherine B ^a   Allan, Stuart M ^a   Rothwell, Nancy J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

AMPA; Cortex; Excitotoxicity; NMDA

Indexed keywords

AMPA RECEPTOR; DIZOCILPINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMINO ACID RECEPTOR BLOCKING AGENT; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID; GLUTAMIC ACID; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN INJURY; CONTROLLED STUDY; CORPUS STRIATUM; MALE; NERVE CELL LESION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CYTOLOGY; DRUG ANTAGONISM; DRUG POTENTIATION; NEOSTRIATUM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; EXCITATORY AMINO ACIDS; GLUTAMIC ACID; INTERLEUKIN-1; MALE; NEOSTRIATUM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; RECEPTORS, INTERLEUKIN-1; RECEPTORS, N-METHYL-D-ASPARTATE; RECOMBINANT PROTEINS;

EID: 0031595870     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.1998.00136.x     Document Type: Article

References (48)

1. Araujo, D.M. (1992) Contrasting effects of specific lymphokines on the survival of hippocampal neurons in culture. In Meyer, E.M. (ed.), Treatment of Dementias. Plenum Press, New York, pp. 113-122.
2. Bederson, J.B., Pitts, L.H., Germano, S.M., Nishimura, M.C., Davis, R.L. & Bartkowski, H.M. (1986) Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke, 17, 1304-1308.
3. Ben-Ari, Y. (1985) Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience, 14, 375-403.
4. Ben-Ari, Y., Tremblay, P., Ottersen, O.P. & Meldrum, B.S. (1980) The role of epileptic activity in hippocampal and remote cerebral lesions induced by kainic acid. Brain Res., 191, 79-97.
5. Biziere, K. & Coyle, J.T. (1978) Influence of cortico-striatal afferents on striatal kainic acid neurotoxicity. Neurosci. Lett., 8, 303-310.
6. Black, M.D., Carey, F., Crossman, A.R., Relton, J.K. & Rothwell, N.J. (1992) Lipocortin-1 inhibits NMDA receptor-mediated neuronal damage in the striatum of the rat. Brain Res., 585, 135-140.
7. Buttini, M., Sauter, A. & Boddeke, H.W.G.M. (1994) Induction of interleukin-1β mRNA after focal cerebral ischaemia in the rat. Mol. Brain Res., 23, 126-134.
8. Cotman, C.W., Monaghan, D.T., Ottersen, L.P. & Storm-Mathisen, J. (1987) Anatomical organization of excitatory amino acid receptors and their pathways. TINS, 10, 273-280.
9. Dinarello, C.A. & Thompson, R.C. (1991) Blocking IL-1: interleukin-1 receptor antagonist in vivo and in vitro. Immunol. Today, 12, 404-410.
10. Frandsen, A., Drejer, J. & Schousboe, A. (1989) Direct evidence that excitotoxicity in cultured neurons is mediated via NMDA as well as non-NMDA receptors. J. Neurochem., 53, 297-299.
11. Fujisawa, H., Dawson, D., Browne, S.E., MacKay, K.B., Bullock, R. & McCulloch, J. (1993) Pharmacological modification of glutamate neurotoxicity in vivo. Brain Res., 629, 73-78.
12. Garthwaite, J. & Garthwaite, G. (1990) Mechanisms of excitatory amino acid neurotoxicity in rat brain slices. Adv. Exp. Med. Biol., 268, 505-518.
13. Hopkins, S.J. & Rothwell, N.J. (1995) Cytokines and the nervous system I: expression and recognition. TINS, 18, 83-88.
14. Iannotti, F., Kida, S., Weller, R., Buhagier, G. & Hillhouse, E. (1993) Interleukin 1β in focal cerebral ischaemia in rats. J. Cereb. Blood Flow Metab., 13, S125.
15. Köhler, C. & Schwarcz, R. (1983) Comparison of ibotenate and kainate neurotoxicity in rat brain: a histological study. Neuroscience, 8, 819-835.
16. Laduron, P.M. (1995) Functional consequences of retrograde axonal transport of receptor-bound neurotensin. TIPS, 16, 338-343.
17. Lees, G.J. & Leong, W. (1994) NBQX prevents contralateral but not ipsilateral seizure-induced cytotoxicity of kainate but not AMPA-reversal at high doses of NBQX. Neuroreport, 5, 2153-2156.
18. Liu, T., McDonnell, P.C., Young, P.R., White, R.F., Siren, A.L., Hallenbeck, J.M., Barone, F.C. & Feuerstein, G.Z. (1993) Interleukin-1β mRNA expression in ischemic rat cortex. Stroke, 24, 1746-1751.
19. Loddick, S.A. & Rothwell, N.J. (1996) Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J. Cereb. Blood Flow Metab., 16, 932-940.
20. Marranes, R. & Wauqier, A. (1988) Episodic barrel rotations induced by intrastriatal injection of quinolinic acid in rats. Inhibition by anticonvulsants. Pharmacol. Biochem. Behav., 31, 153-162.
21. Massieu, L. & Tapia, R. (1994) 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benz(f)quinoxaline protects against both AMPA and kainate-induced lesions in rat striatum in vivo. Neuroscience, 59, 931-938.
22. McGeer, E.G. & McGeer, P.L. (1978) Some factors influencing the neurotoxicity of intrastriatal injections of kainic acid. Neurochem. Res., 3, 501-517.
23. McGeer, E.G., McGeer, P.L. & Singh, K. (1978) Kainate-induced degeneration of neostriatal neurons: dependency upon corticostriatal tract. Brain Res., 139, 381-383.
24. McGeorge, A.J. & Faull, R.L.M. (1989) The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience, 29, 503-537.
25. Meldrum, B. & Garthwaite, J. (1990) Excitatory amino acid neurotoxicity and neurodegenerative disease. TIPS, 11, 379-386.
26. Minami, M., Kuraishi, Y., Yabuuchi, K., Yamazaki, A. & Satoh, M. (1992a) Induction of interleukin-1β mRNA in rat brain after transient forebrain ischemia. J. Neurochem., 58, 390-392.
27. Minami, M., Kuraishi, Y., Yamaguchi, T., Nakai, S., Hirai, Y. & Satoh, M. (1990) Convulsants induce interleukin-1β messenger RNA in rat brain. Biochem. Biophys. Res. Commun., 171, 832-837.
28. Minami, M., Yabuuchi, K., Katsumata, S., Tomozawa, Y., Kuraishi, Y & Satoh, M. (1992b) Possible involvement of interleukin-1 in neuronal cell death after transient forebrain ischaemia. Soc. Neurosci. Abstr., 18, 1013.
29. Nieoullon, A. & Kerkerian-Le Goff, L. (1992) Cellular interactions in the striatum involving neuronal systems using 'classical' neurotransmitters: possible functional implications. Movement Disorders, 7, 311-325.
30. Okazaki, M.M. & Nadler, J.V. (1988) Protective effects of mossy fiber lesions against kainic acid-induced seizures and neuronal degeneration. Neuroscience, 26, 763-781.
31. Parent, A. & Hazrati, L.-N. (1995a) Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res. Rev., 20, 91-127.
32. Parent, A. & Hazrati, L.-N. (1995b) Functional anatomy of the basal ganglia II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res. Rev., 20, 128-154.
33. Paxinos, G. & Watson, C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, London.
34. Relton, J.K. & Rothwell, N.J. (1992) Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res. Bull., 29, 43-46.
35. Rothwell, N.J. & Hopkins, S.J. (1995) Cytokines and the nervous system II: actions and mechanisms of action. TINS, 18, 130-136.
36. Rothwell, N.J., Loddick, S.A. & Lawrence, C.B. (1995) Cytokines and neurodegeneration. In Rothwell, N.J. (ed.), Immune Responses in the Nervous System. Bios Scientific, Oxford, pp. 77-92.
37. Rothwell, N.J. & Relton, J.K. (1993) Involvement of cytokines in acute neurodegeneration in the CNS. Neurosci. Biobehav. Rev., 17, 217-227.
38. Saeed, D., Goetzman, B.W. & Gospe, S.M. (1993) Brain injury and protective effects of hypothermia using triphenyltetrazolium chloride in neonatal rat. Pediatr. Neurol., 9, 263-267.
39. Schwob, J.E., Fuller, T., Price, J.L. & Olney, J.W. (1980) Widespread patterns of neuronal damage following systemic or intracerebral injections of kainic acid: a histological study. Neuroscience, 5, 991-1014.
40. Strijbos, P.J.L.M. & Rothwell, N.J. (1995) Interleukin-1β attenuates excitatory amino acid-induced neurodegeneration in vitro: involvement of nerve growth factor. J. Neuroscience, 15, 3468-3474.
41. Stroemer, R.P. & Rothwell, N.J. (1997) Cortical protection by localized striatal injection of IL-1ra following cerebral ischemia in the rat. J. Cereb. Blood Flow Metab., 17, 597-604.
42. Taupin, V., Toulmond, S., Serrano, A., Benavides, J. & Zavala, F. (1993) Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre- and-post-traumatic treatment with Ro5, 4864, a peripheral-type (p site) benzodiazepine ligand. J. Neuroimmunol., 42, 177-185.
43. Toulmond, S. & Rothwell, N.J. (1995) Interleukin-1 receptor antagonist inhibits neuronal damage caused by fluid percussion injury in the rat. Brain Res., 671, 261-266.
44. Wang, X., Yue, T.-L., Barone, F.C., White, R.F., Gagnon, R.C. & Feuerstein, G.Z. (1994) Concomitant cortical expression of TNF-α and IL-β mRNAs follow early response gene expression in transient focal ischemia. Mol. Chem. Neuropath., 23, 103-114.
45. Wozniak, D.F., Huss, J. & Olney, J.W. (1994) Quisqualate injection into the nucleus basalis magnocellularis produces seizure-related brain damage that is prevented by MK-801. Exp. Neurol., 126, 101-111.
46. Yabuuchi, K., Minami, M., Katsumata, S. & Satoh, M. (1993) In situ hybridization study of interleukin-1β mRNA induced by kainic acid in the rat brain. Mol. Brain Res., 20, 153-161.
47. Yamasaki, Y., Matsuura, N., Shozuhara, H., Onodera, H., Itoyama, Y. & Kogure, K. (1995) Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke, 26, 676-681.
48. Zaczek, R., Simonton, S. & Coyle, J.T. (1978) Local and distant neuronal degeneration following intrastriatal injection of kainic acid. J. Neuropathol. Exp. Neurol., 39, 245-264.